Monoclonal B cell lymphocytosis: Clinical and population perspectives

Cytometry Part B - Clinical Cytometry

Volumn 78, Issue SUPPL. 1, 2010, Pages

  Caporaso, Neil E ^a   Marti, Gerald E ^b   Landgren, Ola ^a   Azzato, Elizabeth ^a   Weinberg, J Brice ^c   Goldin, Lynn ^a   Shanafelt, Tait ^d  

^a NATIONAL CANCER INSTITUTE   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^c DUKE UNIVERSITY   (United States)

^d MAYO CLINIC   (United States)

Author keywords

Chronic lymphocytic leukemia; Lymphocytosis; Monoclonal B cell lymphocytosis; Population

Indexed keywords

B LYMPHOCYTE; CHRONIC LYMPHATIC LEUKEMIA; DISEASE COURSE; HUMAN; LYMPHOCYTOSIS; MOLECULAR GENETICS; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

B-LYMPHOCYTES; BONE MARROW TRANSPLANTATION; CLONE CELLS; DISEASE PROGRESSION; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LYMPHOCYTE COUNT; LYMPHOCYTOSIS; RISK FACTORS; TISSUE DONORS;

EID: 77956600320     PISSN: 15524949     EISSN: 15524957     Source Type: Journal    
DOI: 10.1002/cyto.b.20555     Document Type: Review

References (43)

1. Marti G, Abbasi F, Raveche E, Rawstron AC, Ghia P, Aurran T, Caporaso N, Shim YK, Vogt RF. Overview of monoclonal B-cell lymphocytosis. Br J Haematol 2007;139:701-708.
2. Marti GE, Rawstron AC, Ghia P, Hillmen P, Houlston RS, Kay N, Schleinitz TA, Caporaso N. Diagnostic criteria for monoclonal B-cell lymphocytosis. Br J Haematol 2005;130:325-332. (Pubitemid 43899581)
3. Marti GE, Carter P, Abbasi F, Washington GC, Jain N, Zenger VE, Ishibe N, Goldin L, Fontaine L, Weissman N, et al. B-cell monoclonal lymphocytosis and B-cell abnormalities in the setting of familial Bcell chronic lymphocytic leukemia. Cytometry B Clin Cyto 2003;52B:1-12. (Pubitemid 38297638)
4. Delage R, Jacques L, Massinga-Loembe M, Poulin J, Bilodeau D, Mignault C, Leblond PF, Darveau A. Persistent polyclonal B-cell lymphocytosis: Further evidence for a genetic disorder associated with B-cell abnormalities. Br J Haematol 2001;114:666-670. (Pubitemid 32953649)
5. Hilsenbeck SG, Kurucz C, Duncan RC. Estimation of completeness and adjustment of age-specific and age-standardized incidence rates. Biometrics 1992;48:1249-1262. (Pubitemid 23066496)
6. Amato D, Oscier DG, Davis Z, Mould S, Zheng J, Kolomietz E, Wang C. Cytogenetic aberrations and immunoglobulin VH gene mutations in clinically benign CD5-monoclonal B-cell lymphocytosis. Am J Clin Pathol 2007;128:333-338. (Pubitemid 47262634)
7. Hallek M, Cheson BD, Catovsky D, Caligaris-Cappio F, Dighiero G, Dohner H, Hillmen P, Keating MJ, Montserrat E, Rai KR, Kipps TJ. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: A report from the international workshop on chronic lymphocytic leukemia updating the national cancer institute-working group 1996 guidelines. Blood 2008;111:5446-5456.
8. Mulligan CS, Thomas ME, Mulligan SP. Lymphocytes, B lymphocytes, and clonal CLL cells: Observations on the impact of the new diagnostic criteria in the 2008 guidelines for chronic lymphocytic leukemia (CLL). Blood 2009;113:6496-7; author reply 6497-6498.
9. Shanafelt T, Hanson CA. Monoclonal B-cell lymphocytosis: Definitions and natural history. Leuk Lymphoma 2009;50:493-497.
10. Shanafelt TD, Kay NE, Call TG, Zent CS, Jelinek DF, LaPlant B, Morice WG, Hanson CA. MBL or CLL: Which classification best categorizes the clinical course of patients with an absolute lymphocyte count >or= 5 x 10(9) L(-1) but a B-cell lymphocyte count <5 x 10(9) L(-1)? Leuk Res 2008;32:1458-1461.
11. Nieto WG, Almeida J, Romero A, Teodosio C, Lopez A, Henriques AF, Sanchez ML, Jara-Acevedo M, Rasillo A, Gonzalez M, Fernandez-Navarro P, Vega T, Orfao A. Increased frequency (12%) of circulating chronic lymphocytic leukemia-like B-cell clones in healthy subjects using a highly sensitive multicolor flow cytometry approach. Blood 2009;114:33-37.
12. Rawstron AC, Bennett F, Hillmen P. The biological and clinical relationship between CD5+23+ monoclonal B-cell lymphocytosis and chronic lymphocytic leukaemia. Br J Haematol 2007;139:724-729. (Pubitemid 350115727)
13. Rawstron AC, Bennett FL, O'Connor SJ, Kwok M, Fenton JA, Plummer M, de Tute R, Owen RG, Richards SJ, Jack AS, Hillmen P. Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia. N Engl J Med 2008;359:575-583.
14. Goldin LR, Ishibe N, Sgambati M, Marti GE, Fontaine L, Lee MP, Kelley JM, Scherpbier T, Buetow KH, Caporaso NE. A genome scan of 18 families with chronic lymphocytic leukaemia. Br J Haematol 2003;121:866-873.
15. Goldin LR, Pfeiffer RM, Li X, Hemminki K. Familial risk of lymphoproliferative tumors in families of patients with chronic lymphocytic leukemia: Results from the Swedish family-cancer database. Blood 2004;104:1850-1854.
16. Vogt RF, Shim YK, Middleton DC, Buffler PA, Campolucci SS, Lybarger JA, Marti GE. Monoclonal B-cell lymphocytosis as a biomarker in environmental health studies. Br J Haematol 2007;139:690-700.
17. Landgren O, Albitar M, Ma W, Abbasi F, Hayes RB, Ghia P, Marti GE, Caporaso NE. B-cell clones as early markers for chronic lymphocytic leukemia. N Engl J Med 2009;360, 659-667.
18. Kyle RA, Therneau TM, Rajkumar SV, Larson DR, Plevak MF, Offord JR, Dispenzieri A, Katzmann JA, Melton LJ, III. Prevalence of monoclonal gammopathy of undetermined significance. N Engl J Med 2006;354:1362-1369.
19. Blair A, Purdue MP, Weisenburger DD, Baris D. Chemical exposures and risk of chronic lymphocytic leukaemia. Br J Haematol 2007;139:753-761.
20. Dores GM, Anderson WF, Curtis RE, Landgren O, Ostroumova E, Bluhm EC, Rabkin CS, Devesa SS, Linet MS. Chronic lymphocytic leukaemia and small lymphocytic lymphoma: Overview of the descriptive epidemiology. Br J Haematol 2007;139:809-819.
21. Linet MS, Schubauer-Berigan MK, Weisenburger DD, Richardson DB, Landgren O, Blair A, Silver S, Field RW, Caldwell G, Hatch M, Dores GM. Chronic lymphocytic leukaemia: An overview of aetiology in light of recent developments in classification and pathogenesis. Br J Haematol 2007;139:672-686.
22. Morton LM, Wang SS, Devesa SS, Hartge P, Weisenburger DD, Linet MS. Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood 2006;107:265-276.
23. Slager SL, Kay NE, Fredericksen ZS, Wang AH, Liebow M, Cunningham JM, Vachon CM, Call TG, Cerhan JR. Susceptibility genes and B-chronic lymphocytic leukaemia. Br J Haematol 2007;139:762-771.
24. Di Bernardo MC, Crowther-Swanepoel D, Broderick P, Webb E, Sellick G, Wild R, Sullivan K, Vijayakrishnan J, Wang Y, Pittman AM, Sunter NJ, Hall AG, Dyer MJ, Matutes E, Dearden C, Mainou-Fowler T, Jackson GH, Summerfield G, Harris RJ, Pettitt AR, Hillmen P, Allsup DJ, Bailey JR, Pratt G, Pepper C, Feganm C, Allan JM, Catovsky D, Houlston RS. A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia. Nat Genet 2008;40: 1204-1210.
25. Sellick GS, Goldin LR, Wild RW, Slager SL, Ressenti L, Strom SS, Dyer MJ, Mauro FR, Marti GE, Fuller S, et al. A high-density SNP genome- wide linkage search of 206 families identifies susceptibility loci for chronic lymphocytic leukemia. Blood 2007;110:3326-3333.
26. Goldin LR, Lanasa MC, Slager SL, Cerhan JR, Vachon CM, Strom SS, Camp NJ, Spector LG, Leis JF, Morrison VA, Glenn M, Rabe KG, Achenbach SJ, Allgood SD, Abbasi F, Fontaine L, Yau M, Rassenti LZ, Kay NE, Call TG, Hanson CA, Weinberg JB, Marti GE, Caporaso NE. Common occurrence of monoclonal B-cell lymphocytosis among members of high-risk CLL families. British Journal of Haematology 2010; in press.
27. Tsai HT, Caporaso NE, Kyle RA, Katzmann JA, Dispenzieri A, Hayes RB, Marti GE, Albitar M, Ghia P, Rajkumar SV, Landgren O. Evidence of serum immunoglobulin abnormalities up to 9.8 years before diagnosis of chronic lymphocytic leukemia: A prospective study. Blood 2009;114:4928-4932.
28. Dagklis A, Fazi C, Scarfo L, Apollonio B, Ghia P. Monoclonal B lymphocytosis in the general population. Leuk Lymphoma 2009;50:490-492.
29. Hardy NM, Grady C, Pentz R, Stetler-Stevenson M, Raffeld M, Fontaine LS, Babb R, Bishop MR, Caporaso N, Marti GE. Bioethical considerations of monoclonal B-cell lymphocytosis: donor transfer after haematopoietic stem cell transplantation. Br J Haematol 2007; 139:824-831.
30. Shanafelt TD, Kay NE, Jenkins G, Call TG, Zent CS, Jelinek DF, Morice WG, Boysen J, Zakko L, Schwager S, et al. B-cell count and survival: Differentiating chronic lymphocytic leukemia from monoclonal B-cell lymphocytosis based on clinical outcome. Blood 2009;113:4188-4196.
31. Shanafelt TD, Kay NE, Rabe KG, Call TG, Zent CS, Maddocks K, Jenkins G, Jelinek DF, Morice WG, Boysen J, Dores GM. Brief report: natural history of individuals with clinically recognized monoclonal B-cell lymphocytosis compared with patients with Rai 0 chronic lymphocytic leukemia. J Clin Oncol 2009;27:3959-3963.
32. Shanafelt TD, Ghia P, Lanasa MC, Landgren O, Rawstron AC. Monoclonal B-cell lymphocytosis (MBL): Biology, natural history and clinical management. Leukemia 2010;24:512-520.
33. Morice WG, Kurtin PJ, Hodnefield JM, Shanafelt TD, Hoyer JD, Remstein ED, Hanson CA. Predictive value of blood and bone marrow flow cytometry in B-cell lymphoma classification: Comparative analysis of flow cytometry and tissue biopsy in 252 patients. Mayo Clin Proc 2008;83:776-785.
34. Rawstron AC. Monoclonal B-cell lymphocytosis. Hematol Am Soc Hematol Educ Program 2009;430-439.
35. Shim YK, Vogt RF, Middleton D, Abbasi F, Slade B, Lee KY, Marti GE. Prevalence and natural history of monoclonal and polyclonal Bcell lymphocytosis in a residential adult population. Cytometry B Clin Cyto 2007;72B:344-353.
36. Rossi D, Sozzi E, Puma A, De Paoli L, Rasi S, Spina V, Gozzetti A, Tassi M, Cencini E, Raspadori D, et al. The prognosis of clinical monoclonal B cell lymphocytosis differs from prognosis of Rai 0 chronic lymphocytic leukaemia and is recapitulated by biological risk factors. Br J Haematol 2009;146:64-75.
37. Fung SS, Hillier KL, Leger CS, Sandhu I, Vickars LM, Galbraith PF, Li CH, Leitch HA. Clinical progression and outcome of patients with monoclonal B-cell lymphocytosis. Leuk Lymphoma 2007;48: 1087-1091.
38. Hanson CA, Kurtin PJ, Dogan A. The proposed diagnostic criteria change for chronic lymphocytic leukemia: Unintended consequences? Blood 2009;113:6495-6496.
39. Goldin LR, Slager SL, Caporaso NE. Familial chronic lymphocytic leukemia. Curr Opin Hematol 2010;17:350-355.
40. Pavletic SZ, Zhou G, Sobocinski K, Marti G, Doney K, DiPersio J, Feremans W, Foroni L, Goodman S, Prentice G, et al. Genetically identical twin transplantation for chronic lymphocytic leukemia. Leukemia 2007;21:2452-2455.
41. Perz JB, Ritgen M, Moos M, Ho AD, Kneba M, Dreger P. Occurrence of donor-derived CLL 8 years after sibling donor SCT for CML. Bone Marrow Transplant 2008;42:687-688.
42. Sala-Torra O, Hanna C, Loken MR, Flowers ME, Maris M, Ladne PA, Mason JR, Senitzer D, Rodriguez R, Forman SJ, Deeg HJ, Radich JP. Evidence of donor-derived hematologic malignancies after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2006;12:511-517.
43. Del Giudice I, Mauro FR, De Propris MS, Starza ID, Armiento D, Iori AP, Torelli GF, Guarini A, Foa R. Identification of monoclonal B-cell lymphocytosis among sibling transplant donors for chronic lymphocytic leukemia patients. Blood 2009;114:2848-2849.